Study guide
SMILE, surgical selection and complications
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
SMILE, surgical selection and complications
Key Takeaways Explain This Topic AI
SMILE removes a lenticule and differs from flap-based ablation in anatomy and recovery.
Thickness and tissue-alteration ratios are risk markers rather than standalone guarantees of safety.
Interface inflammation, infection and ectasia require distinct diagnosis and treatment.
Last updated: October 2026
4. Small Incision Lenticule Extraction (SMILE)
Small Incision Lenticule Extraction (SMILE) is an all-femtosecond intrastromal refractive procedure that eliminates both excimer photoablation and corneal flap creation.
Surgical Technique
Using a low-energy, high-frequency femtosecond laser (e.g., VisuMax, 500 kHz 500\text{ kHz} 500 kHz ), four sequential photodisruptive cuts are performed within the stroma:
Refractive Lenticule Posterior Interface : The deeper cutting plane created from the periphery towards the centre, forming the posterior refractive surface.
Lenticule Edge : A vertical cylindrical cut ( 10 – 15 μ m 10–15\,\mu\text{m} 10–15 μ m thick) defining the outer boundary of the lenticule.
Refractive Lenticule Anterior Interface (Cap) : The superficial lamellar plane created from the centre outwards, situated at a fixed depth of 100 – 120 μ m 100–120\,\mu\text{m} 100–120 μ m beneath the anterior epithelial surface.
Side-Cut Entry Tunnel : A small, arcuate 2 – 4 mm 2–4\text{ mm} 2–4 mm incision (typically at the 12 o'clock or superotemporal position).
Manual dissection is performed using a dedicated pocket-separator spatula to free the anterior and posterior planes, followed by extraction of the intrastromal lenticule through the side cut with micro-forceps.
Biomechanical & Neurological Advantages
Biomechanics: Anterior stromal lamellae contribute strongly to corneal strength. A small-incision lenticule procedure preserves more anterior continuity than a flap, but comparative clinical biomechanics are complex. Neither a fixed 60% strength attribution nor a guaranteed 40–50% LASIK loss applies to every eye. SMILE can still cause ectasia.
Reduced Denervation Dry Eye : The sub-basal nerve plexus arises from long ciliary nerves entering mid-stroma and branching vertically into the sub-epithelial space. In LASIK, flap creation severs these nerves around 300 ∘ 300^\circ 30 0 ∘ of the circumference. SMILE generally causes less early nerve disruption than flap creation in comparative studies, but dry-eye outcomes vary. Pre-existing surface disease, technique and follow-up matter; dry eye and reduced sensation remain possible.
5. Preoperative Patient Selection & Ectasia Risk Stratification
Assess refractive stability, realistic goals, dry eye, corneal sensation, lid disease, pupil, binocular status and ocular comorbidity. Review topography and tomography, pachymetry distribution, contact-lens warpage, family history, atopy and rubbing. A normal anterior map alone does not establish safety.
The historical Randleman Ectasia Risk Score System considers topography, residual stromal bed, age, corneal thickness and refractive error. Its older scoring model does not replace modern tomography or establish universal safety for all procedures.
For LASIK, residual stromal bed (RSB) and percentage of tissue altered (PTA) are: R S B = C C T − ( f l a p + a b l a t i o n ) , P T A = f l a p + a b l a t i o n C C T × 100 % \mathrm{RSB}=\mathrm{CCT}-(\mathrm{flap}+\mathrm{ablation}),\qquad
\mathrm{PTA}=\frac{\mathrm{flap}+\mathrm{ablation}}{\mathrm{CCT}}\times100\% RSB = CCT − ( flap + ablation ) , PTA = CCT flap + ablation × 100%
For CCT 510 micrometres, flap 110 and ablation 100, RSB is 300 micrometres and PTA is 41.2%. A PTA around or above 40% was associated with ectasia in particular LASIK studies. It is a risk marker, not a biological cliff or a validated identical threshold for PRK and SMILE. An RSB of 300 micrometres does not guarantee safety. In a concerning case, defer LASIK and reassess alternatives; PRK is not automatically safe in an ectatic cornea, and a phakic lens requires its own anatomical eligibility assessment.
Explain infection, haze, dry eye, residual error, regression, dysphotopsia and rare loss of best-corrected vision. Surgery changes optical correction but does not remove high-myopia retinal risk. Contact lenses, spectacles and no surgery remain legitimate choices.
- 6. Complications of Keratorefractive Surgery
- Intraoperative Complications
Suction Loss : If suction breaks during femtosecond flap creation, immediately stop laser delivery. If the cut has not crossed into the visual axis, suction can be re-established immediately. If suction breaks during a mechanical microkeratome pass, abort the procedure immediately , reposition the partial flap without laser ablation, and allow 3 to 6 months of healing before re-attempting.
Free cap : Stop and assess tissue integrity and orientation. Replace the viable cap correctly and decide whether to defer ablation; completing ablation is not automatically safe after this complication.
Buttonhole Flap : A central flap defect can occur during mechanical flap creation, with risk influenced by corneal shape and instrument factors. Abort the planned ablation and carefully reposition the flap. Reassess healing, topography and visual quality before considering further surgery. Later surface ablation may be considered in selected eyes, but neither a single keratometry cutoff nor a compulsory six-month PRK-with-MMC pathway applies to every defect.
Opaque Bubble Layer (OBL) : Femtosecond cavitation gas pockets escape anteriorly into the subepithelial or stromal space. Can interfere with excimer eye-tracking systems; surgery should be paused for 15–30 minutes until gas reabsorbs.
Postoperative Complications: Diffuse Lamellar Keratitis (DLK)
Diffuse Lamellar Keratitis ("Sands of the Sahara") is a sterile, non-infectious, diffuse inflammatory infiltrate of polymorphonuclear neutrophils (PMNs) confined strictly to the flap-stromal interface, appearing 1 to 5 days postoperatively. Etiologies include bacterial endotoxins on surgical instruments, microkeratome blade oils, or povidone-iodine entry.
DLK Stage Biomicroscopic Findings Clinical Severity Management Protocol
Grade 1 Fine, white, granular "sandy" infiltrates in the flap periphery, sparing the visual axis Mild; asymptomatic or mild foreign body sensation; BCVA unchanged Intensive topical Prednisolone acetate 1% q1h ; review in 24 hours
Grade 2 Central spread without dense clumping Moderate Intensive topical steroids; consider systemic treatment by severity and reassess closely
Grade 3 Dense central clumping, aggregated granular clusters, interface fluid; marked haze Severe; prominent vision loss, photophobia, foreign body pain Urgent flap lift and interface washout with copious BSS + intensive topical/oral steroids
Grade 4 Stromal tissue loss and scarring Urgent specialist review Flap lifting may worsen tissue loss; individual management and later optical rehabilitation
Caution
Dense central DLK requires urgent specialist treatment, often interface irrigation and intensive anti-inflammatory therapy after excluding infection. Grade 4 is not an automatic indication to lift a structurally compromised flap. Distinguish steroid-related pressure-induced interface fluid from inflammation: escalating steroids can worsen it.
Other Postoperative Complications
Epithelial Ingrowth : Proliferation of epithelial cells into the interface (1–2% of microkeratome LASIK, higher in re-treatments). Staged as mild (peripheral, non-progressive; observe) versus clinically significant (advancing within 2 mm of visual axis, flap melting, foreign body sensation; requires surgical flap lift, mechanical scraping of bed and flap underside, alcohol application, and secure repositioning with sutures or fibrin glue).
Infectious Keratitis : Early onset (days 1–3) is typically staphylococcal or streptococcal; delayed/atypical onset (weeks 2–4) is classically Mycobacterium chelonae , Nocardia , or fungi. Requires urgent sampling and intensive organism-directed treatment. A flap/interface infection often needs flap lifting and interface sampling or irrigation; select antimicrobial coverage with the corneal team, timing and culture findings rather than one compulsory combination.